Erratum

Phase i trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma (Invest New Drugs DOI: 10.1007/s10637-010-9630-0)

Masashi Niwakawa, Katsuyoshi Hashine, Raizo Yamaguchi, Hirofumi Fujii, Yasuo Hamamoto, Koichi Fukino, Takahiko Tanigawa, Yoshiteru Sumiyoshi

Research output: Contribution to journal › Comment/debate

Original languageEnglish
Pages (from-to)1274-1275
Number of pages2
JournalInvestigational New Drugs
Volume30
Issue number3
DOIs
Publication statusPublished - 2012 Jun 1
Externally publishedYes

Fingerprint

Renal Cell Carcinoma
Interferon-alpha
Pharmaceutical Preparations
sorafenib

ASJC Scopus subject areas

  • Oncology
  • Pharmacology
  • Pharmacology (medical)

Cite this

Erratum : Phase i trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma (Invest New Drugs DOI: 10.1007/s10637-010-9630-0). / Niwakawa, Masashi; Hashine, Katsuyoshi; Yamaguchi, Raizo; Fujii, Hirofumi; Hamamoto, Yasuo; Fukino, Koichi; Tanigawa, Takahiko; Sumiyoshi, Yoshiteru.

In: Investigational New Drugs, Vol. 30, No. 3, 01.06.2012, p. 1274-1275.

Research output: Contribution to journal › Comment/debate

Niwakawa, M, Hashine, K, Yamaguchi, R, Fujii, H, Hamamoto, Y, Fukino, K, Tanigawa, T & Sumiyoshi, Y 2012, 'Erratum: Phase i trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma (Invest New Drugs DOI: 10.1007/s10637-010-9630-0)', Investigational New Drugs, vol. 30, no. 3, pp. 1274-1275. https://doi.org/10.1007/s10637-011-9771-9
Niwakawa M, Hashine K, Yamaguchi R, Fujii H, Hamamoto Y, Fukino K et al. Erratum: Phase i trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma (Invest New Drugs DOI: 10.1007/s10637-010-9630-0). Investigational New Drugs. 2012 Jun 1;30(3):1274-1275. https://doi.org/10.1007/s10637-011-9771-9
Niwakawa, Masashi ; Hashine, Katsuyoshi ; Yamaguchi, Raizo ; Fujii, Hirofumi ; Hamamoto, Yasuo ; Fukino, Koichi ; Tanigawa, Takahiko ; Sumiyoshi, Yoshiteru. / Erratum : Phase i trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma (Invest New Drugs DOI: 10.1007/s10637-010-9630-0). In: Investigational New Drugs. 2012 ; Vol. 30, No. 3. pp. 1274-1275.
@article{c24da30e907b47ca8b21e6de893e4250,
title = "Erratum: Phase i trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma (Invest New Drugs DOI: 10.1007/s10637-010-9630-0)",
author = "Masashi Niwakawa and Katsuyoshi Hashine and Raizo Yamaguchi and Hirofumi Fujii and Yasuo Hamamoto and Koichi Fukino and Takahiko Tanigawa and Yoshiteru Sumiyoshi",
year = "2012",
month = "6",
day = "1",
doi = "10.1007/s10637-011-9771-9",
language = "English",
volume = "30",
pages = "1274--1275",
journal = "Investigational New Drugs",
issn = "0167-6997",
publisher = "Kluwer Academic Publishers",
number = "3",

}

TY - JOUR

T1 - Erratum

T2 - Phase i trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma (Invest New Drugs DOI: 10.1007/s10637-010-9630-0)

AU - Niwakawa, Masashi

AU - Hashine, Katsuyoshi

AU - Yamaguchi, Raizo

AU - Fujii, Hirofumi

AU - Hamamoto, Yasuo

AU - Fukino, Koichi

AU - Tanigawa, Takahiko

AU - Sumiyoshi, Yoshiteru

PY - 2012/6/1

Y1 - 2012/6/1

UR - http://www.scopus.com/inward/record.url?scp=84864335743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864335743&partnerID=8YFLogxK

U2 - 10.1007/s10637-011-9771-9

DO - 10.1007/s10637-011-9771-9

M3 - Comment/debate

VL - 30

SP - 1274

EP - 1275

JO - Investigational New Drugs

JF - Investigational New Drugs

SN - 0167-6997

IS - 3

ER -

Access to Document